Concepedia

Serena Ascrizzi

SA

Statistics

Publications

6

Citations

133

H-Index

6

Active since

2022

Affiliations

Magna Graecia University(Current)

Institute for Biomedical Research and Innovation

Temple University

Ospedale Annunziata di Cosenza

Serena Ascrizzi is an author at Magna Graecia University specializing in molecular oncology, multiple myeloma therapy, and multiple myeloma.

ORCID

Publications per year

2022–2024

6

Publications

6

The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma

Katia Grillone, Caterina Riillo, Roberta Rocca et al. · International Journal of Molecular Sciences · 2022 · 36 citations · Full text

, , +17

An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma

Katia Grillone, Serena Ascrizzi, Paolo Cremaschi et al. · Blood · 2024 · 23 citations · Full text

, , +16

A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells

Caterina Riillo, Daniele Caracciolo, Katia Grillone et al. · Cancers · 2022 · 22 citations · Full text

, , +16

Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance

Annachiara Esposito, Antonio De Agostini, Giuseppe Quero et al. · Cell Death and Disease · 2024 · 21 citations · Full text

, , +17

TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma

Francesca Scionti, Giada Juli, Roberta Rocca et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 19 citations · Full text

, , +17

1–5 of 6